Results 11 to 20 of about 8,213 (208)
Interaction of Decay-Accelerating Factor with Coxsackievirus B3 [PDF]
Journal of Virology, 2007 ABSTRACTMany entero-, parecho-, and rhinoviruses use immunoglobulin (Ig)-like receptors that bind into the viral canyon and are required to initiate viral uncoating during infection. However, some of these viruses use an alternative or additional receptor that binds outside the canyon.
Susan, Hafenstein +6 more
openaire +3 more sources
Development of antiviral therapeutics combating coxsackievirus type B3 infection
Инфекция и иммунитет, 2021 Enteroviruses comprise highly diverse group of single-stranded positive RNA viruses belonging to Enterovirus genus, Picornaviridae family. They are the most prevalent viruses worldwide highlighted by high resistance to environmental cues.
A. S. Volobueva +2 more
doaj +3 more sources
Coxsackievirus B3 Exploits the Ubiquitin-Proteasome System to Facilitate Viral Replication
Viruses, 2021 Infection by RNA viruses causes extensive cellular reorganization, including hijacking of membranes to create membranous structures termed replication organelles, which support viral RNA synthesis and virion assembly.
Martin Voss +4 more
doaj +2 more sources
Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis. [PDF]
PLoS ONE, 2012 BACKGROUND: Elevated heart rate is associated with increased cardiovascular morbidity. The selective I(f) current inhibitor ivabradine reduces heart rate without affecting cardiac contractility, and has been shown to be cardioprotective in the failing ...
Li Yue-Chun +6 more
doaj +2 more sources
Major Persistent 5′ Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues
Emerging Infectious Diseases, 2016 We performed deep sequencing analysis of the enterovirus 5′ noncoding region in cardiac biopsies from a patient with dilated cardiomyopathy. Results displayed a mix of deleted and full-length coxsackievirus B3, characterized by a low viral RNA load (8 ...
Alexis Bouin +7 more
doaj +2 more sources
Treatment Trends of Myocarditis with Coxsackievirus B3 infection
Al-Mustansiriyah Journal of Pharmaceutical Sciences, 2020 Viral myocarditis occurred after viral invasion of the cardiocytes and followed by the releasing of viral particles and inflammatory cells. Acute viral myocarditis is relatively common phase of the disease cured spontaneously in some cases or leading to
Dalya Basil Hanna +2 more
doaj +3 more sources
CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis. [PDF]
PLoS ONE, 2017 Studies on inflammatory disorders elucidated the pivotal role of the CX3CL1/CX3CR1 axis with respect to the pathophysiology and diseases progression. Coxsackievirus B3 (CVB3)-induced myocarditis is associated with severe cardiac inflammation, which may ...
Irene Müller +12 more
doaj +2 more sources
Design of 4-Substituted Sulfonamidobenzoic Acid Derivatives Targeting Coxsackievirus B3
Life, 2022 A series of novel 4-substituted sulfonamidobenzoic acid derivatives was synthesized as the structural evolution of 4-(4-(1,3-dioxoisoindolin-2-yl)phenylsulfonamido)benzoic acid, which is the known inhibitor of the enterovirus life cycle.
Anton A. Shetnev +4 more
doaj +2 more sources
American Journal of Perinatology Reports, 2011 We present a case of fetal–neonatal acute myocarditis caused by coxsackievirus B3 infection in a term neonate. The condition manifested as high-grade atrioventricular (A-V) block prenatally.
Hironori Takahashi +6 more
doaj +2 more sources
Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines
Virology Journal, 2018 Background Endometrial cancer (EC) is one of the most common gynecological malignancies globally. Although progress has been made in surgical and other adjuvant therapies, there is still a great need to develop new approaches to further reduce the ...
Yanzhen Lin +9 more
doaj +2 more sources